Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Aprocitentan on Fluid Homeostasis in Healthy Subjects
NCT02708004Phase 1Completed
- Sponsor
- Idorsia
- Start
- Jun 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in hypertension (HTN) comparing Aprocitentan with Placebo (2 arms). Primary endpoint: Body weight. Started Jun 2016; status: completed.
02
Drugs
aprocitentan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02708004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02708004.